中文

佐力药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-27
ItemAmountY/Y
Revenue¥0.90B+8.9%
Gross profit¥0.57B
Operating income¥0.24B
Net income¥0.20B+10.2%
Gross margin63.8%Net margin 22.5%
Revenue Q/Q+18.0%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.32B36.2%
R&D¥0.01B1.2%
SG&A¥0.33B36.7%
Tax & other¥0.04B4.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

捷成股份东软载波力源信息通裕重工永清环保国投智能神农种业维尔利潜能恒信科德教育佳士科技福安药业

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies